Trials / Completed
CompletedNCT01188538
Anti Propionibacterium(P.) Acnes Activity of Epiduo® Gel Compared to Benzoyl Peroxide (BPO) 2.5% Gel
Anti P. Acnes Activity of Epiduo® Gel Compared to Benzoyl Peroxide (BPO) 2.5% Gel in the Treatment of Subjects With Acne Vulgaris
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the antibacterial activity of Epiduo® Gel (Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel) on P. acnes compared to that of Benzoyl Peroxide 2.5% Gel.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Epiduo gel | Once daily application on the face in the evening for 12 weeks |
| DRUG | BPO | Once daily application on the face in the evening for 12 weeks |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2010-08-01
- Completion
- 2010-08-01
- First posted
- 2010-08-25
- Last updated
- 2021-02-18
- Results posted
- 2011-07-07
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT01188538. Inclusion in this directory is not an endorsement.